NASDAQ: OCGNOcugen Inc Stock Ownership - Who owns Ocugen?
Insider buying vs selling
Have Ocugen Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shankar Musunuri | Chief Executive Officer | 2025-01-03 | 177,146 | $0.89 | $158.37kSell |
| Arun Upadhyay | Chief Scientific Officer Head of Research Development and Medical | 2025-01-03 | 41,633 | $0.89 | $37.22kSell |
| Prabhavathi Fernandes | Director | 2024-11-26 | 10,000 | $0.91 | $9.09kBuy |
| Kirsten Castillo | Director | 2024-11-22 | 25,000 | $0.91 | $22.85kBuy |
| Arun Upadhyay | Chief Scientific Officer Head of Research Development and Medical | 2024-09-16 | 842 | $1.17 | $985.14Sell |
| Arun Upadhyay | Chief Scientific Officer Head of Research Development and Medical | 2024-06-17 | 917 | $1.42 | $1.30kSell |
OCGN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when OCGN insiders and whales buy or sell their stock.
OCGN Shareholders
What type of owners hold Ocugen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 6.70% | 19,573,112 | $22.12M | Institution |
| Vanguard Group Inc | 5.71% | 16,683,113 | $18.85M | Institution |
| Geode Capital Management LLC | 2.36% | 6,888,821 | $7.78M | Institution |
| State Street Corp | 2.03% | 5,932,041 | $6.70M | Institution |
| Michael 1. Lewis | 1.90% | 5,548,103 | $6.27M | Insider |
| Wilmslow Estates Ltd | 1.80% | 5,258,859 | $5.94M | Insider |
| Randal J. Kirk | 1.50% | 4,382,936 | $4.95M | Insider |
| Ubs Group Ag | 1.50% | 4,367,780 | $4.94M | Institution |
| Gmt Capital Corp | 1.42% | 4,153,798 | $4.69M | Institution |
| Shankar Musunuri | 1.41% | 4,123,321 | $4.66M | Insider |
OCGN vs Biotech Stocks
Ocugen Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.